These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Bupropion. An antidepressant used to help smoking cessation]. Taeron C Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615 [No Abstract] [Full Text] [Related]
4. [Neuropharmacology of smoking: basic research opens new therapeutic possibilities]. Svensson TH; Grenhoff J Lakartidningen; 1991 May; 88(22):2066-71. PubMed ID: 2051876 [TBL] [Abstract][Full Text] [Related]
5. Current pharmacological treatments for nicotine dependence. George TP; O'Malley SS Trends Pharmacol Sci; 2004 Jan; 25(1):42-8. PubMed ID: 14723978 [TBL] [Abstract][Full Text] [Related]
6. Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status. Buchhalter AR; Fant RV; Henningfield JE Drugs; 2008; 68(8):1067-88. PubMed ID: 18484799 [TBL] [Abstract][Full Text] [Related]
7. Serotonin receptors as potential targets for modulation of nicotine use and dependence. Fletcher PJ; Lê AD; Higgins GA Prog Brain Res; 2008; 172():361-83. PubMed ID: 18772042 [TBL] [Abstract][Full Text] [Related]
8. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models. Smith LC; George O Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566 [TBL] [Abstract][Full Text] [Related]
9. The effect of bupropion on nicotine craving and withdrawal. Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415 [TBL] [Abstract][Full Text] [Related]
10. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. Wing VC; Shoaib M Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868 [TBL] [Abstract][Full Text] [Related]
11. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753 [TBL] [Abstract][Full Text] [Related]
12. Treating tobacco addiction--nicotine or no nicotine? Benowitz NL N Engl J Med; 1997 Oct; 337(17):1230-1. PubMed ID: 9337385 [No Abstract] [Full Text] [Related]
13. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Harrison AA; Liem YT; Markou A Neuropsychopharmacology; 2001 Jul; 25(1):55-71. PubMed ID: 11377919 [TBL] [Abstract][Full Text] [Related]
14. Non-nicotine pharmacotherapy for smoking cessation. Ferry LH Prim Care; 1999 Sep; 26(3):653-69. PubMed ID: 10436292 [TBL] [Abstract][Full Text] [Related]
15. Nicotine dependence: the role for antidepressants and anxiolytics. Sullivan MA; Covey LS Curr Opin Investig Drugs; 2002 Feb; 3(2):262-71. PubMed ID: 12020058 [TBL] [Abstract][Full Text] [Related]
16. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272 [TBL] [Abstract][Full Text] [Related]
17. Bupropion for the treatment of nicotine withdrawal and craving. Mooney ME; Sofuoglu M Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112 [TBL] [Abstract][Full Text] [Related]